Pressmeddelanden

2012-05-03 13:54 CEST Sanofi Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second operation for filling and finishing product at its Waterford, Ireland manufacturing plant.